Larimar Therapeutics Reports Third Quarter 2021 Operating and Financial Results

Go back to Larimar Therapeutics Reports Third Quarter 2021 Operating and Financial Results
(NASDAQ: LRMR) Delayed: 4.20 -0.12 (2.78%)
Previous Close $4.32    52 Week High
Open $4.31    52 Week Low
Day High $4.35    P/E N/A 
Day Low $4.13    EPS
Volume 384,106